ID MSH3_HUMAN Reviewed; 1137 AA. AC P20585; A1L480; A1L482; A6NMM6; Q6PJT5; Q86UQ6; Q92867; DT 01-FEB-1991, integrated into UniProtKB/Swiss-Prot. DT 11-JAN-2011, sequence version 4. DT 27-MAR-2024, entry version 209. DE RecName: Full=DNA mismatch repair protein Msh3; DE Short=hMSH3; DE AltName: Full=Divergent upstream protein; DE Short=DUP; DE AltName: Full=Mismatch repair protein 1; DE Short=MRP1; GN Name=MSH3; Synonyms=DUC1, DUG; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS VAL-79; ARG-949 AND THR-1045. RX PubMed=2722860; DOI=10.1016/s0021-9258(18)81766-5; RA Fujii H., Shimada T.; RT "Isolation and characterization of cDNA clones derived from the divergently RT transcribed gene in the region upstream from the human dihydrofolate RT reductase gene."; RL J. Biol. Chem. 264:10057-10064(1989). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH MSH2, AND VARIANTS RP 57-ALA--ALA-65 DEL; VAL-79 AND ARG-949. RX PubMed=8942985; DOI=10.1073/pnas.93.24.13629; RA Acharya S., Wilson T., Gradia S., Kane M.F., Guerrette S., Marsischky G.T., RA Kolodner R.D., Fishel R.; RT "hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6."; RL Proc. Natl. Acad. Sci. U.S.A. 93:13629-13634(1996). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-79; ARG-949 AND RP THR-1045. RA Shimada T., Ikejima M., Watanabe A., Orimo H.; RL Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ALA-ALA-ALA-62 INS; VAL-79; RP LEU-709; ARG-949 AND THR-1045. RG NIEHS SNPs program; RL Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15372022; DOI=10.1038/nature02919; RA Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S., RA Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M., RA She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S., RA Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M., RA Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M., RA Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T., RA Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., RA Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R., RA Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L., RA Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N., RA Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., RA Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., RA Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.; RT "The DNA sequence and comparative analysis of human chromosome 5."; RL Nature 431:268-274(2004). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS 57-ALA--ALA-65 DEL; RP VAL-79; ARG-949 AND THR-1045. RC TISSUE=Muscle; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP POSSIBLE INVOLVEMENT IN ENDMC. RX PubMed=8782829; DOI=10.1038/ng0996-102; RA Risinger J.I., Umar A., Boyd J., Berchuck A., Kunkel T.A., Barrett J.C.; RT "Mutation of MSH3 in endometrial cancer and evidence for its functional RT role in heteroduplex repair."; RL Nat. Genet. 14:102-105(1996). RN [8] RP INTERACTION WITH EXO1. RX PubMed=11427529; DOI=10.1074/jbc.m102670200; RA Schmutte C., Sadoff M.M., Shim K.-S., Acharya S., Fishel R.; RT "The interaction of DNA mismatch repair proteins with human exonuclease RT I."; RL J. Biol. Chem. 276:33011-33018(2001). RN [9] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1099, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=20068231; DOI=10.1126/scisignal.2000475; RA Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., RA Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.; RT "Quantitative phosphoproteomics reveals widespread full phosphorylation RT site occupancy during mitosis."; RL Sci. Signal. 3:RA3-RA3(2010). RN [10] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [11] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1099, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21406692; DOI=10.1126/scisignal.2001570; RA Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., RA Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.; RT "System-wide temporal characterization of the proteome and phosphoproteome RT of human embryonic stem cell differentiation."; RL Sci. Signal. 4:RS3-RS3(2011). RN [12] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-33, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma, and Erythroleukemia; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). RN [13] RP IDENTIFICATION IN THE MMR COMPLEX, AND INTERACTION WITH MCM9. RX PubMed=26300262; DOI=10.1016/j.molcel.2015.07.010; RA Traver S., Coulombe P., Peiffer I., Hutchins J.R., Kitzmann M., RA Latreille D., Mechali M.; RT "MCM9 Is Required for Mammalian DNA Mismatch Repair."; RL Mol. Cell 59:831-839(2015). RN [14] RP VARIANT ALA-ALA-ALA-62 INS. RX PubMed=8851770; DOI=10.1007/bf01900603; RA Nakajima E., Orimo H., Ikejima M., Shimada T.; RT "Nine-bp repeat polymorphism in exon 1 of the hMSH3 gene."; RL Jpn. J. Hum. Genet. 40:343-345(1995). RN [15] RP VARIANTS VAL-79 AND THR-1045. RX PubMed=10944853; DOI=10.1007/s100380070031; RA Orimo H., Nakajima E., Yamamoto M., Ikejima M., Emi M., Shimada T.; RT "Association between single nucleotide polymorphisms in the hMSH3 gene and RT sporadic colon cancer with microsatellite instability."; RL J. Hum. Genet. 45:228-230(2000). RN [16] RP INVOLVEMENT IN FAP4. RX PubMed=27476653; DOI=10.1016/j.ajhg.2016.06.015; RA Adam R., Spier I., Zhao B., Kloth M., Marquez J., Hinrichsen I., Kirfel J., RA Tafazzoli A., Horpaopan S., Uhlhaas S., Stienen D., Friedrichs N., RA Altmueller J., Laner A., Holzapfel S., Peters S., Kayser K., Thiele H., RA Holinski-Feder E., Marra G., Kristiansen G., Noethen M.M., Buettner R., RA Moeslein G., Betz R.C., Brieger A., Lifton R.P., Aretz S.; RT "Exome Sequencing Identifies Biallelic MSH3 Germline Mutations as a RT Recessive Subtype of Colorectal Adenomatous Polyposis."; RL Am. J. Hum. Genet. 99:337-351(2016). CC -!- FUNCTION: Component of the post-replicative DNA mismatch repair system CC (MMR). Heterodimerizes with MSH2 to form MutS beta which binds to DNA CC mismatches thereby initiating DNA repair. When bound, the MutS beta CC heterodimer bends the DNA helix and shields approximately 20 base CC pairs. MutS beta recognizes large insertion-deletion loops (IDL) up to CC 13 nucleotides long. After mismatch binding, forms a ternary complex CC with the MutL alpha heterodimer, which is thought to be responsible for CC directing the downstream MMR events, including strand discrimination, CC excision, and resynthesis. CC -!- SUBUNIT: Component of the DNA mismatch repair (MMR) complex composed at CC least of MSH2, MSH3, MSH6, PMS1 and MLH1 (PubMed:26300262). Heterodimer CC consisting of MSH2-MSH3 (MutS beta) (PubMed:8942985). Forms a ternary CC complex with MutL alpha (MLH1-PMS1). Interacts with EXO1 CC (PubMed:11427529). Interacts with MCM9 (PubMed:26300262). CC {ECO:0000269|PubMed:11427529, ECO:0000269|PubMed:26300262, CC ECO:0000269|PubMed:8942985}. CC -!- INTERACTION: CC P20585; P40692: MLH1; NbExp=5; IntAct=EBI-1164205, EBI-744248; CC P20585; P43246: MSH2; NbExp=12; IntAct=EBI-1164205, EBI-355888; CC P20585; P12004: PCNA; NbExp=6; IntAct=EBI-1164205, EBI-358311; CC -!- DISEASE: Endometrial cancer (ENDMC) [MIM:608089]: A malignancy of CC endometrium, the mucous lining of the uterus. Most endometrial cancers CC are adenocarcinomas, cancers that begin in cells that make and release CC mucus and other fluids. {ECO:0000305|PubMed:8782829}. Note=Disease CC susceptibility is associated with variants affecting the gene CC represented in this entry. CC -!- DISEASE: Familial adenomatous polyposis 4 (FAP4) [MIM:617100]: A form CC of familial adenomatous polyposis, a condition characterized by the CC development of multiple colorectal adenomatous polyps, benign neoplasms CC derived from glandular epithelium. Some affected individuals may CC develop colorectal carcinoma. FAP4 inheritance is autosomal recessive. CC {ECO:0000269|PubMed:27476653}. Note=The disease is caused by variants CC affecting the gene represented in this entry. CC -!- SIMILARITY: Belongs to the DNA mismatch repair MutS family. MSH3 CC subfamily. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAH11817.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305}; CC -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and CC Haematology; CC URL="https://atlasgeneticsoncology.org/gene/341/MSH3"; CC -!- WEB RESOURCE: Name=NIEHS-SNPs; CC URL="http://egp.gs.washington.edu/data/msh3/"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; J04810; AAB47281.1; -; mRNA. DR EMBL; U61981; AAB06045.1; -; mRNA. DR EMBL; D61419; BAD27111.1; -; Genomic_DNA. DR EMBL; AY275681; AAP13535.1; -; Genomic_DNA. DR EMBL; AC008434; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC010270; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC022493; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC011817; AAH11817.1; ALT_SEQ; mRNA. DR EMBL; BC130434; AAI30435.1; -; mRNA. DR EMBL; BC130436; AAI30437.1; -; mRNA. DR CCDS; CCDS34195.1; -. DR PIR; A33507; A33507. DR RefSeq; NP_002430.3; NM_002439.4. DR PDB; 3THW; X-ray; 3.09 A; B=219-1134. DR PDB; 3THX; X-ray; 2.70 A; B=219-1134. DR PDB; 3THY; X-ray; 2.89 A; B=219-1134. DR PDB; 3THZ; X-ray; 4.30 A; B=219-1134. DR PDB; 8OLX; EM; 3.10 A; B=1-1137. DR PDB; 8OM5; EM; 3.52 A; B=1-1137. DR PDB; 8OM9; EM; 3.32 A; B=1-1137. DR PDB; 8OMA; EM; 3.29 A; B=1-1137. DR PDB; 8OMO; EM; 3.43 A; B=1-1137. DR PDB; 8OMQ; EM; 3.11 A; B=1-1137. DR PDBsum; 3THW; -. DR PDBsum; 3THX; -. DR PDBsum; 3THY; -. DR PDBsum; 3THZ; -. DR PDBsum; 8OLX; -. DR PDBsum; 8OM5; -. DR PDBsum; 8OM9; -. DR PDBsum; 8OMA; -. DR PDBsum; 8OMO; -. DR PDBsum; 8OMQ; -. DR AlphaFoldDB; P20585; -. DR EMDB; EMD-16964; -. DR EMDB; EMD-16969; -. DR EMDB; EMD-16971; -. DR EMDB; EMD-16972; -. DR EMDB; EMD-16973; -. DR EMDB; EMD-16974; -. DR SMR; P20585; -. DR BioGRID; 110574; 106. DR ComplexPortal; CPX-77; DNA mismatch repair MutSbeta complex. DR CORUM; P20585; -. DR DIP; DIP-35127N; -. DR IntAct; P20585; 26. DR MINT; P20585; -. DR STRING; 9606.ENSP00000265081; -. DR iPTMnet; P20585; -. DR PhosphoSitePlus; P20585; -. DR BioMuta; MSH3; -. DR DMDM; 317373576; -. DR EPD; P20585; -. DR jPOST; P20585; -. DR MassIVE; P20585; -. DR MaxQB; P20585; -. DR PaxDb; 9606-ENSP00000265081; -. DR PeptideAtlas; P20585; -. DR ProteomicsDB; 53762; -. DR Pumba; P20585; -. DR Antibodypedia; 24651; 329 antibodies from 32 providers. DR CPTC; P20585; 1 antibody. DR DNASU; 4437; -. DR Ensembl; ENST00000265081.7; ENSP00000265081.6; ENSG00000113318.11. DR GeneID; 4437; -. DR KEGG; hsa:4437; -. DR MANE-Select; ENST00000265081.7; ENSP00000265081.6; NM_002439.5; NP_002430.3. DR UCSC; uc003kgz.5; human. DR AGR; HGNC:7326; -. DR CTD; 4437; -. DR DisGeNET; 4437; -. DR GeneCards; MSH3; -. DR HGNC; HGNC:7326; MSH3. DR HPA; ENSG00000113318; Low tissue specificity. DR MalaCards; MSH3; -. DR MIM; 600887; gene. DR MIM; 608089; phenotype. DR MIM; 617100; phenotype. DR neXtProt; NX_P20585; -. DR OpenTargets; ENSG00000113318; -. DR Orphanet; 480536; MSH3-related attenuated familial adenomatous polyposis. DR PharmGKB; PA31134; -. DR VEuPathDB; HostDB:ENSG00000113318; -. DR eggNOG; KOG0218; Eukaryota. DR GeneTree; ENSGT00550000074949; -. DR HOGENOM; CLU_002472_0_1_1; -. DR InParanoid; P20585; -. DR OMA; HIAPCEL; -. DR OrthoDB; 168255at2759; -. DR PhylomeDB; P20585; -. DR TreeFam; TF300525; -. DR PathwayCommons; P20585; -. DR Reactome; R-HSA-5358606; Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta). DR Reactome; R-HSA-5632927; Defective Mismatch Repair Associated With MSH3. DR Reactome; R-HSA-5632928; Defective Mismatch Repair Associated With MSH2. DR SignaLink; P20585; -. DR BioGRID-ORCS; 4437; 13 hits in 1155 CRISPR screens. DR ChiTaRS; MSH3; human. DR GeneWiki; MSH3; -. DR GenomeRNAi; 4437; -. DR Pharos; P20585; Tbio. DR PRO; PR:P20585; -. DR Proteomes; UP000005640; Chromosome 5. DR RNAct; P20585; Protein. DR Bgee; ENSG00000113318; Expressed in bronchial epithelial cell and 214 other cell types or tissues. DR ExpressionAtlas; P20585; baseline and differential. DR GO; GO:0016020; C:membrane; HDA:UniProtKB. DR GO; GO:0032302; C:MutSbeta complex; IDA:HGNC-UCL. DR GO; GO:0005654; C:nucleoplasm; TAS:Reactome. DR GO; GO:0005634; C:nucleus; IDA:UniProtKB. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0140664; F:ATP-dependent DNA damage sensor activity; IEA:InterPro. DR GO; GO:0003690; F:double-stranded DNA binding; IBA:GO_Central. DR GO; GO:0019899; F:enzyme binding; IPI:UniProtKB. DR GO; GO:0030983; F:mismatched DNA binding; IEA:InterPro. DR GO; GO:0006281; P:DNA repair; IDA:BHF-UCL. DR GO; GO:0043570; P:maintenance of DNA repeat elements; IMP:HGNC-UCL. DR GO; GO:0006298; P:mismatch repair; IDA:ComplexPortal. DR GO; GO:0006312; P:mitotic recombination; IBA:GO_Central. DR GO; GO:0045910; P:negative regulation of DNA recombination; IDA:BHF-UCL. DR GO; GO:0051096; P:positive regulation of helicase activity; IDA:BHF-UCL. DR GO; GO:0016447; P:somatic recombination of immunoglobulin gene segments; IBA:GO_Central. DR Gene3D; 1.10.1420.10; -; 2. DR Gene3D; 3.40.1170.10; DNA repair protein MutS, domain I; 1. DR Gene3D; 3.30.420.110; MutS, connector domain; 1. DR Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1. DR IDEAL; IID00612; -. DR InterPro; IPR007695; DNA_mismatch_repair_MutS-lik_N. DR InterPro; IPR000432; DNA_mismatch_repair_MutS_C. DR InterPro; IPR007696; DNA_mismatch_repair_MutS_core. DR InterPro; IPR016151; DNA_mismatch_repair_MutS_N. DR InterPro; IPR036187; DNA_mismatch_repair_MutS_sf. DR InterPro; IPR007860; DNA_mmatch_repair_MutS_con_dom. DR InterPro; IPR036678; MutS_con_dom_sf. DR InterPro; IPR045076; MutS_family. DR InterPro; IPR027417; P-loop_NTPase. DR PANTHER; PTHR11361:SF122; DNA MISMATCH REPAIR PROTEIN MSH3; 1. DR PANTHER; PTHR11361; DNA MISMATCH REPAIR PROTEIN MUTS FAMILY MEMBER; 1. DR Pfam; PF01624; MutS_I; 1. DR Pfam; PF05188; MutS_II; 1. DR Pfam; PF05192; MutS_III; 1. DR Pfam; PF00488; MutS_V; 1. DR SMART; SM00534; MUTSac; 1. DR SMART; SM00533; MUTSd; 1. DR SUPFAM; SSF55271; DNA repair protein MutS, domain I; 1. DR SUPFAM; SSF53150; DNA repair protein MutS, domain II; 1. DR SUPFAM; SSF48334; DNA repair protein MutS, domain III; 1. DR SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1. DR PROSITE; PS00486; DNA_MISMATCH_REPAIR_2; 1. DR Genevisible; P20585; HS. PE 1: Evidence at protein level; KW 3D-structure; ATP-binding; DNA damage; DNA repair; DNA-binding; KW Nucleotide-binding; Phosphoprotein; Reference proteome. FT CHAIN 1..1137 FT /note="DNA mismatch repair protein Msh3" FT /id="PRO_0000115192" FT REGION 31..122 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 75..297 FT /note="Interaction with EXO1" FT /evidence="ECO:0000269|PubMed:11427529" FT REGION 201..222 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 31..45 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 62..76 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 80..107 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 896..903 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255" FT MOD_RES 33 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 1099 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:20068231, FT ECO:0007744|PubMed:21406692" FT VARIANT 57..65 FT /note="Missing" FT /evidence="ECO:0000269|PubMed:15489334, FT ECO:0000269|PubMed:8942985" FT /id="VAR_020934" FT VARIANT 62 FT /note="A -> AAAA" FT /evidence="ECO:0000269|PubMed:8851770" FT /id="VAR_020935" FT VARIANT 79 FT /note="I -> V (in dbSNP:rs1650697)" FT /evidence="ECO:0000269|PubMed:10944853, FT ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:2722860, FT ECO:0000269|PubMed:8942985, ECO:0000269|Ref.3, FT ECO:0000269|Ref.4" FT /id="VAR_020936" FT VARIANT 709 FT /note="F -> L (in dbSNP:rs1805354)" FT /evidence="ECO:0000269|Ref.4" FT /id="VAR_016160" FT VARIANT 789 FT /note="Y -> F (in dbSNP:rs10067975)" FT /id="VAR_055251" FT VARIANT 949 FT /note="Q -> R (in dbSNP:rs184967)" FT /evidence="ECO:0000269|PubMed:15489334, FT ECO:0000269|PubMed:2722860, ECO:0000269|PubMed:8942985, FT ECO:0000269|Ref.3, ECO:0000269|Ref.4" FT /id="VAR_016161" FT VARIANT 1045 FT /note="A -> T (in dbSNP:rs26279)" FT /evidence="ECO:0000269|PubMed:10944853, FT ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:2722860, FT ECO:0000269|Ref.3, ECO:0000269|Ref.4" FT /id="VAR_016162" FT VARIANT 1054 FT /note="T -> A (in dbSNP:rs1805131)" FT /id="VAR_016163" FT CONFLICT 61 FT /note="A -> T (in Ref. 6; AAI30435)" FT /evidence="ECO:0000305" FT CONFLICT 622 FT /note="E -> G (in Ref. 1; AAB47281 and 3; BAD27111)" FT /evidence="ECO:0000305" FT HELIX 231..240 FT /evidence="ECO:0007829|PDB:3THX" FT TURN 241..245 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 246..251 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 253..259 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 260..270 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 275..277 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 280..286 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 287..289 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 290..300 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 304..309 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 313..316 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 328..334 FT /evidence="ECO:0007829|PDB:3THX" FT TURN 342..344 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 347..349 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 354..356 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 368..374 FT /evidence="ECO:0007829|PDB:3THX" FT TURN 382..384 FT /evidence="ECO:0007829|PDB:3THW" FT STRAND 386..393 FT /evidence="ECO:0007829|PDB:3THX" FT TURN 395..397 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 400..407 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 412..421 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 424..431 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 434..445 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 449..451 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 454..458 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 460..462 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 465..475 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 497..512 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 516..519 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 522..524 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 525..528 FT /evidence="ECO:0007829|PDB:3THX" FT TURN 531..533 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 539..544 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 547..549 FT /evidence="ECO:0007829|PDB:3THX" FT TURN 551..553 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 560..564 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 570..581 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 587..601 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 607..613 FT /evidence="ECO:0007829|PDB:3THX" FT TURN 614..617 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 621..629 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 635..661 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 666..672 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 674..678 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 680..682 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 683..686 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 691..696 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 706..708 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 710..737 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 745..747 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 750..757 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 761..763 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 769..773 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 775..781 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 783..814 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 815..817 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 818..841 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 843..845 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 850..854 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 856..862 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 865..870 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 875..877 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 880..884 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 886..888 FT /evidence="ECO:0007829|PDB:3THY" FT STRAND 891..896 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 900..917 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 922..930 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 933..938 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 952..965 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 971..976 FT /evidence="ECO:0007829|PDB:3THX" FT TURN 977..980 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 983..999 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 1004..1008 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 1012..1016 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 1017..1020 FT /evidence="ECO:0007829|PDB:3THX" FT TURN 1021..1024 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 1025..1033 FT /evidence="ECO:0007829|PDB:3THX" FT STRAND 1055..1062 FT /evidence="ECO:0007829|PDB:3THX" FT TURN 1066..1069 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 1070..1073 FT /evidence="ECO:0007829|PDB:3THX" FT TURN 1074..1077 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 1080..1111 FT /evidence="ECO:0007829|PDB:3THX" FT HELIX 1116..1128 FT /evidence="ECO:0007829|PDB:3THX" SQ SEQUENCE 1137 AA; 127412 MW; FBAE6B84D3F86032 CRC64; MSRRKPASGG LAASSSAPAR QAVLSRFFQS TGSLKSTSSS TGAADQVDPG AAAAAAAAAA AAPPAPPAPA FPPQLPPHIA TEIDRRKKRP LENDGPVKKK VKKVQQKEGG SDLGMSGNSE PKKCLRTRNV SKSLEKLKEF CCDSALPQSR VQTESLQERF AVLPKCTDFD DISLLHAKNA VSSEDSKRQI NQKDTTLFDL SQFGSSNTSH ENLQKTASKS ANKRSKSIYT PLELQYIEMK QQHKDAVLCV ECGYKYRFFG EDAEIAAREL NIYCHLDHNF MTASIPTHRL FVHVRRLVAK GYKVGVVKQT ETAALKAIGD NRSSLFSRKL TALYTKSTLI GEDVNPLIKL DDAVNVDEIM TDTSTSYLLC ISENKENVRD KKKGNIFIGI VGVQPATGEV VFDSFQDSAS RSELETRMSS LQPVELLLPS ALSEQTEALI HRATSVSVQD DRIRVERMDN IYFEYSHAFQ AVTEFYAKDT VDIKGSQIIS GIVNLEKPVI CSLAAIIKYL KEFNLEKMLS KPENFKQLSS KMEFMTINGT TLRNLEILQN QTDMKTKGSL LWVLDHTKTS FGRRKLKKWV TQPLLKLREI NARLDAVSEV LHSESSVFGQ IENHLRKLPD IERGLCSIYH KKCSTQEFFL IVKTLYHLKS EFQAIIPAVN SHIQSDLLRT VILEIPELLS PVEHYLKILN EQAAKVGDKT ELFKDLSDFP LIKKRKDEIQ GVIDEIRMHL QEIRKILKNP SAQYVTVSGQ EFMIEIKNSA VSCIPTDWVK VGSTKAVSRF HSPFIVENYR HLNQLREQLV LDCSAEWLDF LEKFSEHYHS LCKAVHHLAT VDCIFSLAKV AKQGDYCRPT VQEERKIVIK NGRHPVIDVL LGEQDQYVPN NTDLSEDSER VMIITGPNMG GKSSYIKQVA LITIMAQIGS YVPAEEATIG IVDGIFTRMG AADNIYKGQS TFMEELTDTA EIIRKATSQS LVILDELGRG TSTHDGIAIA YATLEYFIRD VKSLTLFVTH YPPVCELEKN YSHQVGNYHM GFLVSEDESK LDPGAAEQVP DFVTFLYQIT RGIAARSYGL NVAKLADVPG EILKKAAHKS KELEGLINTK RKRLKYFAKL WTMHNAQDLQ KWTEEFNMEE TQTSLLH //